Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Pfizer (Sweden)
h-index: 59
Total citations: 15,221
Total papers: 440
Homepage:
https://www.pfizer.se/
Recent papers from Pfizer (Sweden)
External Validation of the DAPT Score in a Nationwide Population
Journal of the American College of Cardiology · 2018
Migraine treatment experience in Denmark: results from the nationwide DREAM study with 58000 respondents
The Journal of Headache and Pain · 2026
Assessing the consistency of overall survival extrapolations in Swedish health technology assessment reports of oncology treatments using extended follow-up data
Journal of Medical Economics · 2026
Effectiveness of Rimegepant for the Acute Treatment of Migraine Among Participants Using Different Types of Preventive Therapy: Analyses from CONFIDENCE
Neurology and Therapy · 2026
Protein Biomarkers in Risk and Prognosis of Amyotrophic Lateral Sclerosis
European Journal of Neurology · 2026
Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data
Journal of Neuromuscular Diseases · 2026
Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit–cost analysis
Expert Review of Vaccines · 2026
Consistency of response to rimegepant for the acute treatment of migraine among real-world users – findings from the prospective observational CONFIDENCE study
The Journal of Headache and Pain · 2026
Reasons for Discontinuing Triptans Among Current Users of Rimegepant for the Acute Treatment of Migraine in the CONFIDENCE Study (P8-15.018)
Neurology · 2026
Understanding Real-world Perspectives of Healthcare Providers on Short-term Prevention for Migraine and Rimegepant Treatment Use by Patients: Findings from Cross-sectional Surveys (P8-15.017)
Neurology · 2026
A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US
Cephalalgia · 2026
Economic evaluation of a bivalent respiratory syncytial virus prefusion F vaccine for maternal vaccination in Sweden: cost-effectiveness and budget impact
Journal of Medical Economics · 2026
Evaluating the impact of a statewide intervention on multiple myeloma bispecific T-cell engaging antibody (BsAb) therapy uptake in Florida (FL).
Journal of Clinical Oncology · 2026
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome
Cell · 2026
Real-world treatment patterns and outcomes of patients with multiple myeloma initiating elranatamab: results from the ALTITUDE-1 and ALTITUDE-2 retrospective cohort studies
Future Oncology · 2026
Comorbid depression or anxiety among migraine patients aged ten years or older living in Sweden in 2015 to 2023: A nationwide study
Cephalalgia · 2026
Real-world untreated risk of hospitalization and death in a nirmatrelvir/ritonavir treatment-eligible population with mild-to-moderate COVID-19 in the United States: a systematic literature review
BMC Infectious Diseases · 2026
Trends in Hospitalisations Due to Respiratory Syncytial Virus in Swedish Children: A Nationwide Study 2010-2022.
2026
Association of migraine with subsequent risk of depression or anxiety by small-area deprivation: national cohort study with sibling analysis
The Journal of Headache and Pain · 2026
Geographical patterns and determinants of migraine in persons aged ten years or older living in Sweden from 2015 to 2023: a nationwide cross-sectional study
The Journal of Headache and Pain · 2026